Related Experiment Videos
On a new continuous cell line (TM-1) derived from malignant melanoma
The Tohoku Journal of Experimental Medicine
|July 1, 1979
Summary
A new continuous cell line, TM-1, derived from malignant melanoma, has been established. This cell line exhibits reversible changes in melanin production and cell morphology, demonstrating potential for melanoma research.
Area of Science:
- Oncology
- Cell Biology
- Dermatology
Background:
- Malignant melanoma is a significant skin cancer.
- Establishing continuous cell lines is crucial for cancer research.
- Understanding melanoma cell behavior requires in vitro models.
Purpose of the Study:
- To establish and characterize a new continuous cell line from malignant melanoma.
- To investigate the phenotypic plasticity and behavior of melanoma cells in vitro and in vivo.
Main Methods:
- Establishment of a continuous cell line (TM-1) from a patient's lymph node metastasis.
- Dopa staining to assess melanogenesis.
- Treatment with dibutyryl cyclic AMP (DBcAMP) to induce morphological and functional changes.
- Xenotransplantation into nude mice.
- Scanning electron microscopy for cell morphology analysis.
Main Results:
- The TM-1 cell line, derived from malignant melanoma, was successfully established.
- Dopa staining positivity decreased with cell passage, indicating altered melanogenesis.
- DBcAMP treatment induced reversible morphological changes and affected proliferative ability and melanin production.
- TM-1 cells formed tumors in nude mice, composed of epithelioid and spindle cells.
- Both epithelioid and spindle cell morphologies observed in vitro were found to originate from the same cell type.
Conclusions:
- The TM-1 cell line provides a valuable model for studying malignant melanoma.
- Melanoma cells exhibit phenotypic plasticity, with morphology and function influenced by culture conditions and chemical stimuli.
- The established cell line can be used to investigate melanoma progression and therapeutic responses.